ConductScience.org, home
Papers
API referenceFor AI assistants

Paper1192012

e Antigen-antibody system as indicator of liver damage in patients with hepatitis-B antigen.

El Sheikh N and 5 others. Br Med J, 1975. Cited by 113 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. e Antigen-antibody system as indicator of liver damage in patients with hepatitis-B antigen. Papers, record 1192012. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1192012

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
e Antigen-antibody system as indicator of liver damage in patients with hepatitis-B antigen.
PubMed
Journal
Br Med J
PubMed
Year
1975
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
113
iCite
Relative citation ratio, by iCite
5.71
iCite
Revised in PubMed
2019-05-01
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1El Sheikh NN
2Woolf ILI L
3Galbraith RMR M
4Eddleston ALA L
5Dymock IWI W
6Williams RR

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AntigensMajor topic
HepatitisMajor topic
Hepatitis B AntigensMajor topic
Carrier State
Chronic Disease
Hepatitis Viruses
Humans
Liver

Source PubMed

References9

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
155,324Characterization of a new antigen-antibody system associated with hepatitis B.Clin Exp Immunol1975https://conductscience.org/library/papers/55324PubMed
24,106,744The heterogeneity of Australia antigen.J Infect Dis1971https://conductscience.org/library/papers/4106744PubMed
34,138,200Incidence and meaning of the "e" determinant among hepatitis-B-antigen positive patients with acute and chronic liver diseases. Report from the Copenhagen Hepatitis Acuta Programme.Lancet1974https://conductscience.org/library/papers/4138200PubMed
44,175,170A classification of chronic hepatitis.Lancet1968https://conductscience.org/library/papers/4175170PubMed
54,188,622Prognosis of chronic persistent hepatitis.Lancet1970https://conductscience.org/library/papers/4188622PubMed
64,850,682Asymptomatic liver disease in hepatitis B antigen carriers.J Clin Pathol1974https://conductscience.org/library/papers/4850682PubMed
74,116,763New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants.J Immunol1972https://conductscience.org/library/papers/4116763PubMed
84,143,591New antigen-antibody system in Australia-antigen-positive hepatitis.Lancet1971https://conductscience.org/library/papers/4143591PubMed
94,235,815Additional specificities of Australia antigen and the possible identification of hepatitis carriers.Nature1969https://conductscience.org/library/papers/4235815PubMed

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 113 citations.

PMIDTitleJournalYearIn PapersSource
7,333,448A study on the relationship between the prognosis of chronic active hepatitis and the HBV associated antigen/antibody systems.Gastroenterol Jpn1981https://conductscience.org/library/papers/7333448PubMed
7,253,541IgM antibody to hepatitis B core antigen (anti-HBc IgM) in "healthy" HBsAg carriers: a longitudinal study of 75 cases.Klin Wochenschr1981https://conductscience.org/library/papers/7253541PubMed
6,840,863The significance of the HBe system in an area highly endemic for hepatitis B virus.Infection1983https://conductscience.org/library/papers/6840863PubMed
6,716,909Hepatitis B e-antigen titres for evaluating infectivity during hepatitis B virus infection.Klin Wochenschr1984https://conductscience.org/library/papers/6716909PubMed
6,368,400The significance of the HBeAg/anti-HBe system in hemodialysis patients. A multicenter study.Infection1984https://conductscience.org/library/papers/6368400PubMed
856,683Immune responses to the hepatitis B surface antigen and liver-specific lipoprotein in acute type B hepatitis.Gut1977https://conductscience.org/library/papers/856683PubMed
849,558Difference in the distribution of e antigen among different ethnic groups in a population of blood donors.Can Med Assoc J1977https://conductscience.org/library/papers/849558PubMed
776,335Immune response to HBsAg and the spectrum of liver lesions in HBsAg-positive patients with chronic renal disease.Br Med J1976https://conductscience.org/library/papers/776335PubMed
731,022e-Antigen: a link between immune response and infectivity in hepatitis B?J Hyg (Lond)1978https://conductscience.org/library/papers/731022PubMed
670,424Viral antigens and antibodies in hepatitis B infection.J Clin Pathol1978https://conductscience.org/library/papers/670424PubMed
642,401Anti-HBc, HBeAg and DNApolymerase activity in healthy HBsAg carriers and patients with inflammatory liver diseases.Klin Wochenschr1978https://conductscience.org/library/papers/642401PubMed
608,568Clinical significance of e-antigen/anti-e, with special reference to HBc-antigen in the liver.Gastroenterol Jpn1977https://conductscience.org/library/papers/608568PubMed
599,184e Antigen and antibody in outbreaks of hepatitis B in two renal dialysis units.J Clin Pathol1977https://conductscience.org/library/papers/599184PubMed
591,632Occurrence of e antigen in acute hepatitis B.J Clin Pathol1977https://conductscience.org/library/papers/591632PubMed
546,799
Radioimmunoassay in the detection of the hepatitis B e antigen/antibody system in asymptomatic carriers of hepatitis B surface antigen. Correlation with serum Dane particle associated DNA polymerase activity.
Infection1979https://conductscience.org/library/papers/546799PubMed
469,016Electron microscopy of hepatitis B virus components in chronic active liver disease.J Clin Pathol1979https://conductscience.org/library/papers/469016PubMed
403,201Correlations between the detection of e antigen or antibody and electron microscopic pattern of hepatitis B surface antigen (HBsAg) associated particles in the serum of HBsAg carriers.J Clin Pathol1977https://conductscience.org/library/papers/403201PubMed
266,736Association of e antigen with Dane particle DNA in sera from asymptomatic carriers of hepatitis B surface antigen.Proc Natl Acad Sci U S A1977https://conductscience.org/library/papers/266736PubMed
230,994Incidence and clinical significance of HBe antigen and antibody in HBsAg-positive various liver diseases.Gastroenterol Jpn1979https://conductscience.org/library/papers/230994PubMed
211,144Incidence and significance of hepatitis B e antigen and antibody in postnecrotic cirrhosis and primary hepatocellular carcinoma.J Clin Microbiol1978https://conductscience.org/library/papers/211144PubMed

See all 23 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1192012

GET https://conductscience.org/api/papers/v1/1192012/cited_by?page=2

API referenceFor AI assistants